Navigating clinical development for rare cancers requires a careful balance between efficiency and inclusivity.
This webinar offers essential guidance for biotech and pharma companies developing oncology trials in this specialized field. Presented by oncology experts Debra Kientop and Dr. Marie Bonneterre, this session provides strategic recommendations to support successful trial design, feasibility, and operational delivery for rare cancer research.
Key Takeaways Include:- Understanding rare cancers and their unique trial needs
- Best practices in protocol design with patient-reported outcomes (PROs)
- Feasibility and operational strategies tailored to rare cancer trials
"*" indicates required fields